GSK, Valeant Submit NDA For Epilepsy Drug

Martin Berman-Gorvine

首页> 外文期刊>Washington Drug Letter >GSK, Valeant Submit NDA For Epilepsy Drug

【24h】

GSK, Valeant Submit NDA For Epilepsy Drug

机译：葛兰素史克（GSK），Valeant提交了针对癫痫药的NDA

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International have filed an NDA for their epilepsy treatment retigabine with the FDA and a marketing authorization application with the European Medicines Agency.rnRetigabine is intended as an adjunctive therapy to treat adult epilepsy patients with partial-onset seizures, the companies say in a statement last week,rnValeant, based in Aliso Viejo, Calif., received an upfront payment of $125 million last year from London-based GSK for collaborating on the development of retigabine.

机译：葛兰素史克（GSK）和Valeant Pharmaceuticals International已向FDA申请了抗癫痫药瑞替加滨的NDA申请，并已向欧洲药品管理局申请了市场许可。两家公司在上周的一份声明中说，总部位于加利福尼亚州阿利索维耶霍的rnValeant去年从伦敦的GSK收到了一笔1.25亿美元的前期付款，用于合作开发可瑞替加滨。

著录项

来源
《Washington Drug Letter》 |2009年第44期|2|共1页
作者
Martin Berman-Gorvine;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. REMS Submission Delays Decision On GSK, Valeant Epilepsy Drug [J] . April Hollis Washington Drug Letter . 2010,第35期

机译：REMS提交延误了对GSK（有效癫痫药）的决策
2. Panel Voices Support for GSK, Valeant Seizure Drug Potiga [J] . April Hollis Washington Drug Letter . 2010,第32期

机译：面板声音支持GSK，有效缉获毒品Potiga
3. Oxidative stress markers in the neocortex of drug-resistant epilepsy patients submitted to epilepsy surgery [J] . RumiàJ., MarmolF., SanchezJ., Epilepsy research . 2013,第1a2期

机译：耐药性癫痫患者接受癫痫手术的新皮质中的氧化应激标志物
4. A Epilepsy Drug Recommendation System by Implicit Feedback and Crossing Recommendation [C] . Chun Chen, Lu Zhang, Xiaopeng Fan, IEEE SmartWorld Conference;Ubiquitous Intelligence Computing Conference;Advanced Trusted Computed Conference;Scalable Computing Communications Conference;Cloud Big Data Computing Conference;Internet of People Conference;Smart City Innovation Conference . 2018

机译：内隐反馈和交叉推荐的癫痫药物推荐系统
5. Antiepileptic Drug Switching and Epilepsy-related Events in Subjects with Epilepsy: A Case-Control Analysis of Health Insurance Claims Data. [D] . Nguyen, Hiep. 2013

机译：癫痫患者的抗癫痫药转换和癫痫相关事件：健康保险理赔数据的病例对照分析。
6. GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis [O] . Emanuela Grassilli, Leonarda Ianzano, Sara Bonomo, -1

机译：GSK3A与GSK3B冗余可调节耐药性和化学疗法诱导的坏死病
7. GSK3A is redundant with GSK3B in modulating drug resistance and chemotherapy-induced necroptosis. [O] . Emanuela Grassilli, Leonarda Ianzano, Sara Bonomo, 2014

机译：GsK3a在调节耐药性和化疗诱导的坏死性凋亡方面与GsK3B是多余的。
8. Standard Reference Materials: SRM 900, Antiepilepsy Drug Level Assay Standard [R] . Reeder, D. J. , Coxon, B. , Enagonio, D. , 1981

机译：标准参考材料：sRm 900，抗癫痫药物水平测定标准

GSK, Valeant Submit NDA For Epilepsy Drug

摘要

著录项

相似文献

相关主题

期刊订阅